Aptiv Solutions Collaborates with Tessella to Offer Comprehensive Adaptive Clinical Trial Design and Execution Capabilities

Published: Feb 28, 2012

RESTON, Va.--(BUSINESS WIRE)--Aptiv Solutions, a global biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today a collaboration with Tessella, a world leader in the provision of science powered technology and consulting services, to deliver integrated early phase adaptive design and execution services to the biopharmaceutical industry.

Back to news